|
|
Ravi Amaravadi, Craig B. Thompson
J Clin Invest. 2005;
115(10):2618
doi:10.1172/JCI26273
Abstract |
Full text
| PDF
T
he Akt and Pim kinases are cytoplasmic serine/threonine kinases that control programmed cell death by phosphorylating substrates that regulate both apoptosis and cellular metabolism. The PI3K-dependent activation of the Akt kinases and the JAK/STAT–dependent induction of the Pim kinases are examples of partially overlapping survival kinase pathways. Pharmacological manipulation of such kinases could have a major impact on the treatment of a wide variety of human diseases including cancer, inflammatory disorders, and ischemic diseases.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(110)
| Title and authors |
Publication |
Year |
The PIM kinases in hematological cancers
Yesid Alvarado, Francis J Giles, Ronan T Swords
|
Expert Rev. Hematol.
|
2012 |
Positive feedback in the AKT/mTOR pathway and its implications for growth signal progression in skeletal muscle cells: an analytical study
Fernando López-Caamal, Míriam R. García, Richard H. Middleton, Heinrich J. Huber
|
Journal of Theoretical Biology
|
2012 |
Bortezomib interferes with C-KIT processing and transforms the t(8;21)-generated fusion proteins into tumor-suppressing fragments in leukemia cells
H.-T. Fang, B. Zhang, X.-F. Pan, L. Gao, T. Zhen, H.-X. Zhao, L. Ma, J. Xie, Z. Liu, X.-J. Yu
|
Proceedings of the National Academy of Sciences
|
2012 |
Implications of promiscuous Pim-1 kinase fragment inhibitor hydrophobic interactions for fragment-based drug design
Andrew C Good, Jinyu Liu, Bradford Hirth, Gary Asmussen, Yibin Xiang, Hans-Peter Biemann, Kimberly A Bishop, Trisha Fremgen, Maria Fitzgerald, Tatiana Gladysheva
|
J. Med. Chem.
|
2012 |
Central role of lactic acidosis in cancer cell resistance to glucose deprivation-induced cell death
Hao Wu, Zonghui Ding, Danqing Hu, Feifei Sun, Chunyan Dai, Jiansheng Xie, Xun Hu
|
J. Pathol.
|
2012 |
PIM1 kinase as a target for cancer therapy
Anna Lena Merkel, Eric Meggers, Matthias Ocker
|
Expert Opin. Investig. Drugs
|
2012 |
Novel potent dual inhibitors of CK2 and Pim kinases with antiproliferative activity against cancer cells
Fabrice Pierre, Collin F. Regan, Marie-Claire Chevrel, Adam Siddiqui-Jain, Diwata Macalino, Nicole Streiner, Denis Drygin, Mustapha Haddach, Sean E. O’Brien, William G. Rice
|
Bioorganic & Medicinal Chemistry Letters
|
2012 |
Paired box gene 5 may modulate Proviral Integration of Moloney virus2gene and protein expression in mature B-cells
Richard Narayansingh, Rodney J. Ouellette
|
Leuk Lymphoma
|
2011 |
Fasudil Ameliorates Rhabdomyolysis-Induced Acute Kidney Injury via Inhibition of Apoptosis
Yuan-da Wang, Li Zhang, Guang-Yan Cai, Xue-guang Zhang, Yang Lv, Quan Hong, Suo-zhu Shi, Zhong Yin, Xiang-fei Liu, Xiang-mei Chen
|
Ren Fail
|
2011 |
Ocimum gratissimum Aqueous Extract Protects H9c2 Myocardiac Cells from H(2)O(2)-Induced Cell Apoptosis through Akt Signalling.
Mu-Jang Lee, Han-Min Chen, Bor-Show Tzang, Chiu-Wen Lin, Chau-Jong Wang, Jer-Yuh Liu, Shao-Hsuan Kao
|
Evid Based Complement Alternat Med
|
2011 |
|
